Navigation Links
Alba Therapeutics Corporation Announces the Next Clinical Trial of Its Lead Compound, Larazotide Acetate and Promotions
Date:3/17/2009

lammatory and Respiratory Diseases at MedImmune where he worked on asthma and mucosal vaccination. He was a Director of Clinical Discovery, Oncology/ Immunology at Bristol-Myers Squibb where he worked on Crohn's disease, rheumatoid arthritis, and transplantation. Dr. Leon received his MD and PhD from Autonomy University, Madrid (Spain), and his PhD work was focused on the pathogenesis and diagnosis of Celiac disease. He completed a residency in Clinical Immunology at Ramon y Cajal Hospital, Madrid where he was elected Resident of the Year in Spain in 2001 (Sanities Prize). Dr. Leon was a postdoctoral fellow in the Laboratory of Clinical Investigation (Mucosal Immunity Section) and in the Laboratory of Molecular Immunology (Mucosal Biology Section) of the National Institutes of Allergy and Infectious Diseases, National Institutes of Health. He has authored or co-authored 60 original peer-reviewed articles, reviews, book chapters and patents.

Linda Arterburn, PhD, formerly Vice President, Preclinical Development and Program Management, has been promoted to Vice President of Development at Alba. Prior to joining Alba in March 2007, Dr. Arterburn was Executive Director of Discovery Research at Martek Biosciences. In this capacity, she initiated an inflammation research program and was lead inventor on two patents involving novel anti-inflammatory lipids. She previously led Clinical Research and Scientific Affairs at Martek where she played a key role in the regulatory authorizations for the addition of Martek's fatty acid products, DHA and ARA, to infant formula in the United States and Canada. Dr. Arterburn also spent seven years at W.R. Grace & Co., where she led an in vitro toxicology research program, and then served as Manager of Technology and Planning. Dr. Arterburn received her PhD in Pharmacology and the Molecular Sciences from the Johns Hopkins University School of Medicine, and her Bachelor's Degree in Biochemistry from the
'/>"/>

SOURCE Alba Therapeutics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
2. Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
3. Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
4. ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimers Disease
5. BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine
6. Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
7. Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
8. PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy
9. DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
10. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
11. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... YORK , January 15, 2014 ... Ltd., the exclusive worldwide distributor of highly sophisticated agro-breeding ... on January 7, 2014, the Company,s board of directors ... Weiner as its new member of the board. ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. (OTC ... U.S. provisional patent application concerning composition of matter, biological ... targeted tumor cell death.  This patent ... double stranded RNA molecules (VSRNAs) which interfere with the ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Worldwide Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
(Date:4/18/2014)... is being prepped to enter the battle against ... certain diseases in remote areas, thanks in part ... aboard the International Space Station on the behavior ... of capillary flow to diagnose infectious diseases such ... a researcher at Northwestern University in Evanston, Ill., ...
(Date:4/18/2014)... one of your worst memories? How did it make ... during a negative personal experience, such as how sad ... to emotional distress, especially when you can,t stop thinking ... up, thinking about the context of the memories, rather ... effective way to alleviate the negative effects of these ...
(Date:4/18/2014)... This news release is available in French . ... breakthrough could revolutionize surgical practice and regenerative medicine. A ... Molle et Chimie (CNRS/ESPCI Paris Tech) and Didier Letourneur ... and Paris 13), has just demonstrated that the principle ... used in vivo to repair soft-tissue organs and tissues. ...
(Date:4/17/2014)... variant specifically associated with the risk of a ... cent of all breast cancer cases. , The ... called invasive lobular carcinoma, gives researchers important clues ... of breast cancer, which can be missed through ... the journal PloS Genetics , was co-led ...
(Date:4/17/2014)... Experimental Biology and Medicine a multidisciplinary ... Paul Kenis in the Institute of Genomic Biology ... Illinois Urbana-Champaign describe their recent work on subcellular ... of cell functions including energy metabolism, signaling, and ... regulating normal cellular behavior, redox status has been ...
Breaking Medicine News(10 mins):Health News:Space-tested fluid flow concept advances infectious disease diagnoses 2Health News:Space-tested fluid flow concept advances infectious disease diagnoses 3Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2
... Students ... to Possible Career Paths, FORT ... chemistry teachers from more than 20 school,districts throughout the state ... focusing on the pharmaceutical research and,development process. They are participating ...
... KANSAS CITY, Mo., June 24 DST Systems, Inc.,(NYSE: ... the second quarter,ending June 30, 2008, on Tuesday, July ... York Stock Exchange., The Company will host a ... Central Time. The dial-in number is (800) 230-1085 and ...
... The following is a,statement by Robert D. Foreman, President ... The Kidney Care Council (KCC) applaud the End Stage,Renal ... for Patients and Providers Act of 2008, H.R. 6331 ... Representatives., "This legislation contains significant and long overdue ...
... LYN kinase is associated with resistance to imatinib (Gleevec) ... in the June 24 online issue of the ... is the standard therapy for newly diagnosed CML patients. ... time. In some patients, resistance develops in response to ...
... compromised blood, oxygen supply, study suggests , , TUESDAY, June ... name Namenda) may help reduce a form of brain ... Children,s Hospital Boston study. , Hypoxic-ischemia, a compromise ... to cerebral palsy and cognitive/behavioral problems. , In experiments ...
... June 24 Blue Cross and Blue Shield,of Illinois ... for,disaster recovery services in areas affected by the current ... hearts go out to the thousands of people who ... by the floods," Paul S. Boulis, BCBSIL,president, said. "Nearly ...
Cached Medicine News:Health News:Iowa Educators Prepare to Teach High School Students How Medicines Are Made 2Health News:Iowa Educators Prepare to Teach High School Students How Medicines Are Made 3Health News:Iowa Educators Prepare to Teach High School Students How Medicines Are Made 4Health News:DST Systems, Inc. Announces Notification of Earnings Release Date 2Health News:The KCC Applauds House Action on ESRD Reform 2Health News:Activation of LYN kinase is associated with imatinib-resistance in CML patients 2Health News:Alzheimer's Drug May Reduce Preemie Brain Injury 2Health News:Blue Cross and Blue Shield of Illinois Donates $25,000 to American Red Cross for Flood Disaster Recovery 2
HemoSite meter can be used to measure the effects of transfusion or the treatment of deficiency states. It is fast, easy, convenient and discrete....
... The Hgb Pro Professional Hemoglobin Testing System ... single-use test strips, used in measuring total ... The Hgb Pro provides the precision, accuracy ... ,The Hgb Pro Professional Hemoglobin Testing System ...
... D-10 Hemoglobin Testing System: The ... in a small package. It provides a ... and B-thalassemia testing into a single platform. ... only a touch screen away and can ...
... hemoglobin testing system (110V) ... for diabetes monitoring, sickle ... hemoglobinopathy screening and multiple ... test. It has bar ...
Medicine Products: